Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Martin Augsten

1PUBLICATIONS

25CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Sep 09, 2024

Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven Cancers.

Birgit Wilding, Lydia Woelflingseder, Anke Baum

Pageof 1

Frequent Collaborators

1 joint publications

Birgit Wilding

1 joint publications

Lydia Woelflingseder

1 joint publications

Anke Baum

1 joint publications

Krzysztof Chylinski

1 joint publications

Gintautas Vainorius

1 joint publications

Neil Gibson

1 joint publications

Irene C Waizenegger

1 joint publications

Daniel Gerlach

1 joint publications

Fiona Spreitzer

1 joint publications

Yukina Shirai

Frequent Collaborators

1 joint publications

Birgit Wilding

1 joint publications

Lydia Woelflingseder

1 joint publications

Anke Baum

1 joint publications

Krzysztof Chylinski

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos

Top Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on : Dec 11, 2017

See more related videos